Aptuit Resource Library

ADME Studies

Wed, 08 Nov 2006 05:00:00 GMT

Analytical Chemistry- Respiratory Technology

Wed, 12 Sep 2007 04:00:00 GMT

API Capabilities

Sun, 04 May 2008 04:00:00 GMT

Aptuit Consulting - Counterfeit and Tamper Analysis

Thu, 05 Apr 2007 04:00:00 GMT

Aptuit Consulting - Counterfeit Drug Product Analysis

Sun, 01 Apr 2007 04:00:00 GMT

Aptuit Consulting - Pharmaceutical IP Expert Services

Fri, 13 Jun 2008 16:00:00 GMT

Aptuit Immunoanalysis

Wed, 26 Nov 2008 17:00:00 GMT

Aptuit Immunogenicity

Mon, 26 Apr 2010 16:00:00 GMT

Aptuit Immunotoxicology

Wed, 26 Nov 2008 17:00:00 GMT

In Vitro Metabolism Services

Mon, 06 Nov 2006 05:00:00 GMT

Aptuit INDiGO TM - API to IND in 26 weeks or less

Wed, 02 Jan 2008 05:00:00 GMT

Aptuit INDiGO TM - Proof of Concept Study

Wed, 02 Jan 2008 17:00:00 GMT

Aptuit Informatics

Wed, 01 Aug 2007 04:00:00 GMT

Clinicopia Connect

Mon, 22 Feb 2010 05:00:00 GMT

Aptuit Informatics - Clinicopia Data Exchange

Thu, 02 Aug 2007 04:00:00 GMT

Aptuit Informatics - Clinicopia Connect

Thu, 02 Aug 2007 04:00:00 GMT

Clinicopia Supply Management

Mon, 22 Feb 2010 05:00:00 GMT

Aptuit Informatics - cMRP

Fri, 03 Aug 2007 04:00:00 GMT

Aptuit Informatics - Forecasting

Sat, 04 Aug 2007 04:00:00 GMT

Aptuit Informatics - Labeling

Sun, 05 Aug 2007 04:00:00 GMT

Aptuit Informatics - Process Execution

Mon, 06 Aug 2007 04:00:00 GMT

Aptuit IVRS

Sat, 01 Sep 2007 04:00:00 GMT

Aptuit Preclinical Maximum Exposure

Tue, 09 Sep 2008 16:00:00 GMT

Quality - Qualified Person

Sat, 01 Sep 2007 04:00:00 GMT

Aseptic UK

Fri, 07 Sep 2007 04:00:00 GMT

Assessment of Potential to Prolong QT Interval

Fri, 10 Nov 2006 05:00:00 GMT

Automated Robotic Powder Dispensing System

Sat, 08 Sep 2007 04:00:00 GMT

Biochemistry Services for Protein and Peptide Drug Substances and Drug Products

Wed, 19 Sep 2007 04:00:00 GMT

Biopharmaceutical and Biotechnology Support

Sun, 09 Sep 2007 04:00:00 GMT

Biopharmaceutical Services

Wed, 01 Nov 2006 04:00:00 GMT

CFS1200 Capsule Filling Machine

Sat, 01 Sep 2007 04:00:00 GMT

Clinical Bioanalytical Services

Tue, 21 Aug 2007 04:00:00 GMT

Clinical Packaging and Logistics Global Network

Thu, 07 Jul 2005 04:00:00 GMT

Clinical Pharmacokinetics and Biostatistics

Thu, 09 Aug 2007 04:00:00 GMT

Comprehensive Clinical Trials Management, Technology and Solutions

Sat, 01 Apr 2006 04:00:00 GMT

Aptuit Consulting - Drug Development Programmes

Mon, 01 Oct 2007 04:00:00 GMT

Aptuit Consulting - Getting you to market faster

Mon, 15 Feb 2010 15:40:00 GMT

Core Battery Services

Thu, 02 Nov 2006 04:00:00 GMT

CPL Project and Clinical Supplies Management

Sat, 08 Sep 2007 04:00:00 GMT

Discovery support to full product development

Wed, 14 Nov 2007 05:00:00 GMT

Drug Product Mapping and Image Studies

Tue, 18 Sep 2007 04:00:00 GMT

Drug Substance Amorphous and Disordered Materials

Mon, 17 Sep 2007 04:00:00 GMT

Drug Substance Crystallization of Difficult Materials and Scaleup

Thu, 20 Sep 2007 04:00:00 GMT

Drug Substance Solid Form Screening Polymorphs Salts Cocrystals

Sun, 16 Sep 2007 04:00:00 GMT

Early Biotheraputic Development

Sat, 01 Nov 2008 04:00:00 GMT

eCTD Readiness Brochure

Thu, 05 Feb 2009 17:00:00 GMT

Efficacy Services

Mon, 16 Jun 2008 04:00:00 GMT

Formulations- Solids, Liquids and Parenterals

Sun, 11 Nov 2007 05:00:00 GMT

Global GMP Manufacturing (US and UK)

Mon, 10 Sep 2007 04:00:00 GMT

Global Primary Packaging

Tue, 04 Sep 2007 04:00:00 GMT

Global Secondary Packaging

Wed, 05 Sep 2007 04:00:00 GMT

Immunoassay Services

Sun, 05 Nov 2006 04:00:00 GMT

In Vivo Cardiovascular Services

Tue, 07 Nov 2006 05:00:00 GMT

LC/MS and GC/MS

Sun, 02 Sep 2007 04:00:00 GMT

Litigation Support

Mon, 03 Sep 2007 04:00:00 GMT

Pharmaceutical Analysis

Tue, 04 Sep 2007 04:00:00 GMT

Physical Chemistry and Spectroscopy

Wed, 05 Sep 2007 04:00:00 GMT

Precision Dosing Using the Xcelodose ® 600

Mon, 16 Aug 2010 13:52:00 GMT

Preclinical and Clinical Bioanalytical Services

Sat, 01 Jul 2006 04:00:00 GMT

Project Management Factsheet

Sat, 01 Sep 2007 04:00:00 GMT

Aptuit Consulting - QT Prolongation Risk Assessment

Tue, 02 Oct 2007 04:00:00 GMT

Radioanalysis Support of Clinical Mass Balance ADME Studies

Sat, 11 Nov 2006 05:00:00 GMT

Rapid Ion Channel Electrophysiology (ICE) Screening Service

Sun, 12 Nov 2006 05:00:00 GMT

Solid State Analytical Services

Sat, 15 Sep 2007 04:00:00 GMT

Toxicology and Pathology

Fri, 06 Jun 2008 16:00:00 GMT

Warehouse, Storage and Distribution

Thu, 06 Sep 2007 04:00:00 GMT

Milestones Winter 2008/9

Thu, 02 Oct 2008 16:00:00 GMT

This edition of Aptuit’s Milestones Newsletter explores the role of the qualified person in clinical trials in the EU, electronic solutions and submission, experimental screening methods to address polymorphism, and provides update on Aptuit’s joint venture in India, Aptuit Laurus.

Milestones Fall 2008

Thu, 25 Sep 2008 16:00:00 GMT

In this fourth edition of Aptuit's Milestones newsletter, Stephen Byrn, Ph.D., addresses the challenges associated with FDA’s Critical Path Initiative and Eyal Barash describes the patent implications of new chemical entities and amorphous states. Technologies, facilities, and expertise within Aptuit's business units are also explored.

Milestones Summer 2008

Mon, 16 Jun 2008 16:00:00 GMT

In this third edition of Milestones read about the art of working with a VC backed company and Kunal Khattar, Executive Director, Aptuit Laurus, explores the current state of the Indian marketplace and partnering with a CRO in this emerging market.

Milestones Summer 2007

Fri, 08 Jun 2007 04:00:00 GMT

In this second edition of Milestones read about the shifting arena of drug development, the critical role of consulting, getting the right form first time and much much more.

Milestones 2006

Mon, 25 Sep 2006 16:00:00 GMT

In the inaugural edition of Milestones, read about the changing dynamic of the drug development industry, service offerings at various Aptuit facilities around the world, Aptuit's recent acquisition of EaglePicher Pharmaceutical's API business, and much more.

Integrating Clinical Supply Systems and Outsourced Service Providers

Tue, 22 Aug 2006 04:00:00 GMT

With biotech and pharma companies increasingly turning to third parties to manage their clinical supply activities, it is critical for these companies to control and track activities in their information systems. This white paper explores the various integration methods available.

Mastering the Extended Clinical Supply Chain: Strategic Advantages for Clinical Trials

Mon, 21 Aug 2006 04:00:00 GMT

Although clinical supply management is often considered a back-office business unit for a sponsor, it is critical to the drug development process. This white paper examines the importance of and strategic advantage of end-to-end IT to manage and control these core activities between contractors and vendors.

Validation: The Seven Steps to Nirvana

Tue, 22 Aug 2006 04:00:00 GMT

The process of introducing an IT product or application into an organization working in a regulated environment involves a series of complex business processes. This white paper examines the importance of and steps to successful validation in a client’s regulatory environment.

Screening and Animal Bioavailability Studies on Itraconazole Amorphous Dispersions

Sat, 01 Nov 2008 04:00:00 GMT

Purpose:Identify amorphous dispersions of itraconazoleto increase bioavailability. Methods:An amorphous dispersion screen was performed using six polymers, two concentrations, and two preparations (flash evaporation, freeze drying). Materials were characterized using XRPD,DSC, TGA, and moisture sorption, and abbreviated physical stability

An Assessment of the Suitability of the Xcelodose600 in the Filling of Blended Products

Thu, 26 Oct 2006 04:00:00 GMT

The propensity for segregation in powder blends in precision filling technologies is not well understood. Concerns exist that the filling processwill promote segregation through a vibratory action. This initial work sets out to monitor blend segregation, and weight uniformity variation, on capsule blends filled using the Xcelodose 600* system as a function of particle size and diluent choice. Additionally, this is compared with the effects of handfilling in early clinical supplies manufacture. Finally, homogeneity will be considered as a function of filling time.

Characterization of API: PolymerMixtures using X-ray Powder Diffraction

Thu, 01 Nov 2007 16:00:00 GMT

Thermal methods are commonly used to determine miscibility of dispersion systems based on the appearance of one or two glass transition (Tg) temperatures, however limitations exist. The purpose of this project was to investigate using x-ray powder diffraction (XRPD) data and computational methods to analyze active pharmaceutical ingredient (API):polymermixtures in order to determine miscibility of these systems.

Cytochrome P450 Inhibition Screening: Validation of an HPLC-MS/MSmethod for CYP1A2, 2C9, 2C19and 3AInhibition

Fri, 15 Sep 2006 04:00:00 GMT

Drug-drug interaction is an important issue during the discovery and development phase of a new drug. The effect of a newdrug on specific probes for various enzymes of cytochrome P450 are routinely examined using in vitro approaches. The invitro data can then be used in guiding the design of potential clinical interaction studies. Therefore the in vitro experimentsmust be performed with absolute confidence in the method used to obtain the data

Evaluation of Semi-Automated Powder in Bottle Filler

Tue, 06 Nov 2007 05:00:00 GMT

The Powder in Bottle (PIB) dosage form is frequently used in Phase I clinical studies. Often the PIB dosage form is continued going into preliminary Phase IIaclinical studies. The quantities required for the Phase IIastudies are larger and the manual fill of bottles is both time consuming and labor intensive when providing large quantities. A system capable of filling both accurately and rapidly would significantly improve efficiency and reduce cost in the pharmaceutical development process.

Use of the anaesthetised guinea pig model in PK/PD modelling for cardiovascular safety; Thioridazine case study

Mon, 01 Sep 2008 04:00:00 GMT

The anaesthetised guinea pig is widely used as a model for screening cardiovascular safety, however, little has been published over it’s sensitivity for use as an early model for safety. Hence it was our aim to use the phenothiazine antipsychotic, thioridazine, in this model to assess the potential for use inPK/PD modelling cardiovascular end points(QTcB interval).

Loss of Torsade de Pointes in a Rabbit Model - The impact of α - Chloralose Formulation

Mon, 01 Sep 2008 04:00:00 GMT

The model of Torsades de Pointes (TdP) in anaesthetised rabbits, as described by Carlsson, is used to determine the impact of a prolonged QT interval vs the risk of TdP. The anaesthetic of choice for this model is α-chloralose; however,a change in commercial availability of α-chloralose to one with higher levels of the ß-anomer produced solubility issues. A review of the literature highlighted that hydroxypropyl-ß-cyclodextrin could be used as a vehicle to produce a 50 mg/mLα-chloralose solution which was stable at room temperature.

Man Vs. Machine - which is better for QT Interval analysis?

Mon, 01 Sep 2008 04:00:00 GMT

The QT interval from an electrocardiogram (ECG) recording is representative of the ventricular repolarisation time with prolongation of this interval being associated with an increased risk of polymorphic ventricular arrhythmias.Therefore the accurate measurement of QT interval in pre-clinical cardiovascular safety testing is clearly important in the reliable detection of QT prolonging agents and the assessment of the associated risk. While automated ECG interval analysis is cost effective it is often inaccurate as aresult of both inter- and intra animal variability in ECG waveform morphology. Although manual analysis of the ECG intervals is perceived to produce the most reliable results, the benefit may be outweighed by the increased time and cost involved.

Non Aqueous Emulsions For Oral Drug Delivery

Mon, 06 Nov 2006 05:00:00 GMT

Oral bioavailability in early development

Wed, 13 Sep 2006 04:00:00 GMT

For most investigators at early stage development, a principle criterion for a dose formulation is to achieve sufficient solubility in the dose vehicle to obtain the target dose concentration. Dose vehicles themselves are alsogenerally as simple as possible.

Validation of an In Vitro Method to Estimate Phenacetin Kinetics Parameters and Assessment of

Wed, 30 Aug 2006 04:00:00 GMT

Our scientists are developing new methods in which to conduct Ethoxyresorufin O-dealkylase (EROD) assays that save time and produce more accurate results.

Validation of an LC-MS/MS method for the In Vitroinhibitory effects of Phenacetin

Wed, 13 Sep 2006 04:00:00 GMT

In vitro drug inhibition data are used in guiding the design of clinical drug interaction studiesor, when no effect is observed in vitro, to claim that no interaction will occur in vivo.Therefore, it is advisable that the in vitro experiments are performed with confidence in themethod used and data obtained. Here we present the validation of phenacetin O -deethylase (CYP1A2) using an HPLC method with tandem mass spectrometric detection.

Validation of a Chronic Portal Vein Cannulation Model in the Rat

Fri, 15 Sep 2006 04:00:00 GMT

Scientific Data Sheet 1: Assessment of Dose Proportionality

Mon, 11 Sep 2006 04:00:00 GMT

Scientific Data Sheet 2: Effect of food on PK

Sun, 10 Sep 2006 04:00:00 GMT

Scientific Data Sheet 3: Simulation of maintenance dose

Sat, 09 Sep 2006 04:00:00 GMT

Scientific Data Sheet 4: Graphical Presentation of Results from Analysis of PD Data

Fri, 08 Sep 2006 04:00:00 GMT

Scientific Data Sheet 5: PK/PD modeling

Thu, 07 Sep 2006 04:00:00 GMT

Comparison of Aquity and Agilent 1200RR

Thu, 12 Oct 2006 04:00:00 GMT

Over the last 5 years significant advances have been made in HPLC. However, the majority of these have focused around a bewildering array of new stationary phases to improve peak shape, reduce tailing, alter selectivity, etc. Recently, a new breakthrough in chromatography has allowed the user to further investigate the potential of the Van Deemter Plot (Figure 1) through the use of smaller sub 2 micron particle size material.

Extraction of basic compounds

Thu, 19 Oct 2006 04:00:00 GMT

This poster describes a case study, involving one analyte (X) and its two metabolites (Y and Z), which were developed for use in treatment of Parkinson’s disease, whereby several aspects of the method transfer required alteration to achieve compatibility with the new site whilst meeting regulatory validation requirements.

Symbiosis sorbent screening

Fri, 27 Oct 2006 04:00:00 GMT

Solid Phase Extraction (SPE) may provide cleaner extracts from biological samples by the selective removal of matrix interferents which may cause ionization suppression or enhancement over methods which employ the use of protein precipitation or liquid-liquid extractions.

Evaluation of the T-Cell dependent antibody response (TDAR) to Tetanus Toxoid (TT)

Mon, 10 Mar 2008 04:00:00 GMT

Tomtec Sorbent Screening

Fri, 27 Oct 2006 04:00:00 GMT

Optimization of the solid phase extraction (SPE) process can be time consuming because of the sequential testing of different sorbent chemistries, and the further optimization of the condition, equilibration, wash and elution steps. In order to speed up and rationalize method development, a sorbent screening experiment was designed and automated on a Tomtec Quadra 96.

Validation of Mechanism Based Inhibition - Our Experience

Tue, 23 May 2006 04:00:00 GMT

Comparison of the Waters Acquity UPLC and Agilent 1200RR Systems for the Analysis of Testosterone and its Hydroxylated

Thu, 12 Oct 2006 04:00:00 GMT

Evaluation of nine reference compounds in a Zebrafish model of cardiac function

Mon, 01 Sep 2008 04:00:00 GMT

The zebrafish has been suggested as a cost effective, early stage, medium throughput, vertebrate test system that would enable in vivo assays to be conducted earlier with lower costs than those for established in vivo assays

AAPS 2009

Mon, 09 Nov 2009 17:00:00 GMT

Los Angeles Convention Centre, Los Angeles, CA

At Aptuit we are dedicated to Science. As the global leader in integrated pharmaceutical serivices, we provide the very best world class drug development and drug discovery solutions. Supported by our industry renowned experts, we are able to offer advice and expertise to help you meet your milestones quickly and efficiently.

To demonstrate our commitment to science we are offering *FREE 10 minute consultation sessions with one of our experts in API and Solid State Chemistry. Drop by our AAPS booth 1339 and let our experts offer advice to help you solve your drug development challenges.

Visit the Aptuit theatre to learn more about our dedication to science and the services we provide by attending one of our presentations:-

Monday Nov 9th
1330pm - General overview of Aptuit Services
1430pm - Amorphous
1515pm - CoCrystals
1600pm - Biochemistry

Tuesday Nov 10th
0930am - Amorphous
1030am - CoCrystals
1115am - Biochemistry
1330pm - General overview of Aptuit Services
1430pm - IP
1515pm - Analytical

Wednesday Nov 11th
0930am - CoCrystals
1030am - Biochemistry
1115am - General overview of Aptuit Services
1330pm - Amorphous

A poster on The Investigation of Protein-Sugar Interaction in the Solid State, authored by H. Zhang, I. Ivanisavic, P.A. Tishmack, D. Sedlak, A.T. Gilkison and S.J Bogdanowich-Knipp will be available for viewing on Wednesday, November 11 from 8:00am to 12:00pm. The poster will be located in the west exhibit hall A.

Visit Aptuit at booth #1339. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com

*Subject to availability

AAPS 2010

Sun, 14 Nov 2010 17:00:00 GMT

Morial Convention Centre, New Orleans, Louisiana

When cultures cross and minds meet exciting things happen that can have a positive impact on human health. That's why in 2010 the International Pharmaceutical Federation's PSWC and the AAPS Annual Meeting will be combined—for the first time ever—to create a truly global event. Thousands of scientists will converge in the thriving and exciting U.S. city of New Orleans to share various perspectives, ideas and cultural learnings in order to improve health through advances in pharmaceutical sciences.

Aptuit will host presentations titled

Aqueous solubility of nutraceutical cocrystals and Polymorphic cocrystals

Times to be confirmed.

Visit Aptuit at booth #2237. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com

AIPLA 2008 Spring Meeting

Wed, 14 May 2008 16:00:00 GMT

Houston, Texas, InterContinental Hotel -

Aptuit Consutling will attend this conference and have a table top display. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuitconsulting.com.

ASQ (American Standard Quality) Meeting

Sat, 21 Mar 2009 16:00:00 GMT

Kathy Oliva-Whalen and Lori Leet will be presenting on regulatory and eCTDs at the ASQ (American Standard Quality) meeting on Saturday, March 21. Organizers expect approximately 100 participants from all areas of healthcare. Other presentation topics include the relationship of quality and risk management to patient safety and best practices in employee development across industries and firm sizes.

Johnson County Community College, Regnier Center
Overland Park, KS

Amorphous Pharmaceutical Materials

Tue, 23 Sep 2008 16:00:00 GMT

This Amorphous Conference will include new options for drug development and provide attendees with an unrivalled paltform from which to launch new ideas.

Also hear from industry leaders as to which amorphous forms of drugs the have developed and why. Learn from their case studies how they stabilised and controlled these forms and what they are used for now.

Dr Igor Ivanisavic will be speaking at this event and we will also have an exhibition stand. To pre-arrange a meeting with an Aptuit representative please contact info@aptuit.com

Bangalore BIO

Thu, 24 Apr 2008 04:00:00 GMT

BIEC, Bangalore, INDIA -

This International trade show is the largest congregation of the biotech fraternity in India. Over 600 conference delegates and 5000 business visitors from across India and overseas will allow unrivaled networking and business opportunities -

Aptuit Laurus will be in attendance at this show on Stand number 4. To pre-arrange a meeting with one of our representatives email info@aptuit.com

BARQA 2008

Wed, 29 Oct 2008 16:00:00 GMT

Edinburgh International Conference Center (EICC)
Edinburgh, Scotland, UK

This is the 2nd Annual Global QA conference which is hosted by BARQA. This conference is a must for any organization or business offering Quality Assurance auditing services and software applications to a regulated industry within a quality environment.

Aptuit will be exhibiting at this exhibition for the first time, to pre-arrange a meeting with one of our representatives please email info@aptuit.com

Bay Bio Meeting

Thu, 16 Apr 2009 16:00:00 GMT

Aptuit Consulting's William Kerns will moderate a panel of industry professionals on the the topic of Accelerated Virtual Drug Development at the April BayBio Meeting.

Accelerated Virtual Drug Development:
Given the current and foreseeable economic environment, companies from early stage and emerging biotech's to large pharmaceutical firms are being forced to do more with less. In an effort to reduce and/or minimize direct expenditures, outsourcing has become part of many a company’s development strategy eliminating the need to incur long term funding commitments for infrastructure. Numerous options now exist for outsourcing but too often lack integration resulting in limited productivity gains. To address this issue there is a paradigm shift underway in drug development by some in the pharmaceutical industry from what was a FIPCO (fully-integrated pharmaceutical company) model to a VIPNET (virtually-integrated pharmaceutical network) model. Creation of novel business arrangements between sponsors and vendors are giving rise to accelerated development in a virtual world where realization of both time and cost savings is clearly apparent. This seminar will describe the benefits and challenges of virtual drug development from the perspective of a virtual company along with a novel approach accomplished through a Virtual Drug Development Agent and show how it is created, and operated along with its features and benefits.

This Session will bring together a panel of experts with different perspectives from biotech, venture capital and virtual organizations from the Bay area -with experience and understanding of how to employ new business arrangements and strategies to sustain growth and drive value in a virtual world.

Moderator:
William D. Kerns DVM, MS, DACVP,President, Aptuit Consulting Inc

Panelists:
Robert G. Urban, Ph.D., Executive Director,
David H. Koch Institute for Integrative Cancer Research, MIT
Johnson Y.N. Lau, M.B., B.S., M.D., F.R.C.P., Chairman, XenoBiotic Laboratories, Chairman, Kinex Pharmaceuticals, Chairman, XBL China
Andrew A. Protter, Ph.D., Vice President, Preclinical Development, Medivation, Inc.
Kenneth M Ferguson, Ph.D., President and CEO, Imvaxyn, Inc

BIO International Convention 2009

Mon, 18 May 2009 04:00:00 GMT

Georgia World Congress Center
Atlanta, GA

The BIO International Convention brings together 20,000 senior level life science professionals to explore valuable partnerships, discuss strategic practices and expand the biotech innovations that help heal, fuel and feed the world.

Visit Aptuit at booth #2824. To pre-arrange a meeting with one of our representatives, please email info@aptuit.com

Bio Korea 2008

Wed, 08 Oct 2008 16:00:00 GMT

Osong Bio-Technoplis
Osong, Chungbuk, Korea

BIO Korea 2008, with the major goal of application on biotechnology in business, will offer a variety of high-level confernece, international exhibition and partnership event and provide an opportunity to find business and technoloty partners.

Aptuit will be attending this event in conjunction with Scottish Development International. To pre-arrange a meeting with one of our representatives please email info@aptuit.com

Bio Korea 2010

Wed, 01 Sep 2010 16:00:00 GMT

COEX, Seoul, Korea

BIO Korea 2010, with the major goal of application on biotechnology in business, will offer a variety of high-level confernece, international exhibition and partnership event and provide an opportunity to find business and technoloty partners.

Aptuit will be attending this event in conjunction with Scottish Development International. To pre-arrange a meeting with one of our representatives please email info@aptuit.com

BIO USA

Tue, 17 Jun 2008 04:00:00 GMT

San Diego Convention Center, San Diego, California, USA - Join more than 20,k000 executives, investors, scientists, researchers, policy makers and journalists from around the world. Partner with pioneers who are making advances in healthcare and bring vision to grow your business - Aptuit will be exhibiting on Booth 2537 at this event. If you would like to pre-arrange a meeting with one of our Executives attending this event please email info@aptuit.com

BIOMed Israel, 2009

Mon, 15 Jun 2009 16:00:00 GMT

David Intercontinental & Dan Panorama Hotel, Tel Aviv, Israel -

This International Stem Cell Meeting is a prestigious international event bringing together world-renowned scientists at the frontier of embryonic and adult stem cell research. -

Aptuit will be exhibiting at this event. To pre-arrange a meeting with an Aptuit representative please email info@aptuit.com

BIOMed Israel, 2010

Mon, 14 Jun 2010 16:00:00 GMT

David Intercontinental & Dan Panorama Hotel, Tel Aviv, Israel

This International Stem Cell Meeting is a prestigious international event bringing together world-renowned scientists at the frontier of embryonic and adult stem cell research. -

Aptuit will be exhibiting at this event. To pre-arrange a meeting with an Aptuit representative please email info@aptuit.com

William Mackin to speak at BioTaiwan 2008 Exhibition

Thu, 24 Jul 2008 16:00:00 GMT

William Mackin, Ph.D., and Principal with Aptuit Consulting will be exhibiting and speaking at BioTaiwan at the Taipei World Trade Centre from July 24 – 27, 2008.

Dr. Mackin will be presenting From Idea to IND: The Emerging Role of Virtual Drug Development Teams. Learn how the use of virtual drug development teams can reduce costs, provide greater flexibility and experience and increase speed to market in this interesting and thought provoking discussion.

BioTrinity 2009

Thu, 02 Apr 2009 16:00:00 GMT

Kassam Stadium, Oxford, UK

BioTrinity 2009 unites the UK’s life science industry. Come and experience what will be the best biotech partnering and investment conference in the country through this two-day programme. Join top-notch industry executives, including the South East region’s most innovative biotech entrepreneurs, major pharmaceutical companies, life science research leaders, policy makers and internationally prominent investors at the biotechnology event of the year. Aptuit will have a representative speaking at this event, for more information or to arrange a meeting email info@aptuit.com

ChemOutsourcing 2008

Mon, 08 Sep 2008 16:00:00 GMT

Ocean Place Resort, Long Branch, NJ

ChemOutsourcing2008 will bewidely attended by large, mid-sized, and small pharmaceutical/biotech company executives and scientists who are seeking education on the subject of outsourcing to suppliers within the pharmaceutical industry.

Mr Stuart Needleman, Vice President Sales and Marketing at Aptuit will be speaking at this event and Aptuit will be exhibiting. To pre-arrange a meeting with one of our representatives pleasecontact info@aptuit.com

Strategies for Successful Management of Global Clinical Trials Seminar

Fri, 04 Apr 2008 16:00:00 GMT

Sponsored by Aptuit, Inc. and World CourierFriday, April 4, 200811:30 am - 2:30 pm - lunch includedMarriott Princeton Hotel & Conference Center at Forrestal100 College Road East Princeton, NJ 08540

Expert speakers will address the issues surrounding the management of Global Clinical Trials, including what you need to know to meetthe challenges. You will also have an opportunity to network with colleagues, industry resources and question our experienced panel.

For more information, click here.

Questions? Email ask@aptuit.com

Clinical Trial Supply 2008

Tue, 21 Oct 2008 16:00:00 GMT

Angus MacLeod, Senior Manager, Global Depot Network, will present on October 22, 2008 at 3:20 pm.

His presentation,Challenges to controlled drug distribution, will cover:

Exploring trial/molecule specific facility licenses to store and distribute narcotic clinical trial materials
Moving clinical trial materials between countries: specific import and export licenses needed and obstacles faced
Controlled drug capacity at depots
Analyzing different country requirements for different schedules of controlled drugs

Clinical Trial Supply Europe, 2009

Tue, 24 Feb 2009 17:00:00 GMT

The Intercontinental Hotel, Vienna, Austria

Now in its 10th successful year, the Clinical Trial Supply conference will once again bring together leading manufacturers and industry experts to discuss and debate the major challenges facing the clinical supply function today.

With more trials being held globally than ever before, supply systems need to become increasingly sophisticated in order to cope with cross-border transit, different packaging and labeling requirements and more players involved in the process. With this in mind, Clinical Trial Supply 2009 will again create a high-level platform from which to find answers to these challenges and more.

From effective outsourcing and ensuring a streamlined distribution network to the latest developments in clinical supply technology, this conference will provide ample opportunities for discussion and networking with other manufacturers in order to establish best practice methods for approaching this complex issue

Aptuit are proud to be sponsoring and exhibiting at this event. Angus MacLeod, Senior Manager, Global Depot Network, will also present at this event.
His presentation, Challenges to controlled drug distribution, will cover:

Exploring trial/molecule specific facility licenses to store and distribute narcotic clinical trial materials
Moving clinical trial materials between countries: specific import and export licenses needed and obstacles faced
Controlled drug capacity at depots
Analyzing different country requirements for different schedules of controlled drugs

To set up a meeting with an Aptuit representative at this event please email info@aptuit.com

Pharmaceutical Co-Crystals

Tue, 23 Sep 2008 16:00:00 GMT

Moevenpick Hotel Amsterdam City Centre, Amsterdam, Netherlands

Translating Co-Crystal Properties, Screening and Design into Commercial Success

Pharmaceutical Co-Crystals 2008, is the only conferences focusing on purely co-crystal drugs, and will provide you with the unique opportunity to network with individuals working within the field, with ten networking opportunities, you can really maximise your time out of office by gaining answers to all those niggling research questions.

Learn form the successes and failures of others on how to incorporate to best translate co-crystal properties, screening and design, into a commercially successful product.

Aptuit is a participating sponsor of this event.

Dr Scott Childs, Snr Research Chemist, Aptuit, Inc will be presenting on the topic - Is There Anything New We Can Learn From Carbamazepine? Optimising Co-Crystal Screening Strategies Using Phase Diagrams And The Analysis Of A Family Of Related Crystal Structures Using Materials Mercury

To pre-arrange a meeting with an Aptuit representative please email info@aptuit.com

CPhI 2008

Tue, 30 Sep 2008 16:00:00 GMT

Gathering in Frankfurt, this three day event will attract everyone from manufacturers and purchasers of fine chemicals and pharmaceuticals to solution providers, all in search of the latest industry developments.

Aptuit will be exhibiting in Hall 4.0 on stand 40H13. To pre-arrange a meeting with one of our representatives please contact info@aptuit.com

CPhI Japan 2009

Tue, 21 Apr 2009 16:00:00 GMT

Tokyo Big Sight Exhibition Centre

CPhI Japan is the biggest pharmaceutical ingredients exhibition held in Japan, can only partly explain its success. It's the combination of high quality organisation and a high quality targeted audience that makes CPhI so appealing to companies to participate in this high profile event.The success in attracting such a large number of potential Japanese business-partners makes CPhI Japan especially compelling for companies from other parts of the world, since it provides them with a platform to:

- Introduce their company to the Japanese market
- Reinforce their company's position in the Japanese market
- Bolster Japanese partner/distributor marketing activity
- Launch new products in the Japanese market
- Make new contacts and expand their Japanese network

Aptuit will be exhibiting at this event, if you would like to set up a meeting with and Aptuit representative, please email info@aptuit.com

Clinical Supply Support Group West Meeting

Thu, 06 Nov 2008 17:00:00 GMT

TOPIC: An Overview of the Clinical Supply Chain Process

Including:

Building and Maintaining Effective Communications with Clinical Operations
Understanding the Roles and Responsibilities of the Qualified Person (QP)

OBJECTIVES: At the conclusion of this meeting, participants will be able to:

Identify the challenges in building and maintaining effective communication with Clinical Operations.
Identify the responsibilities of the QP.
List at least three ways to positively influence their Clinical Trial Supply delivery.

LOCATION: HILTON LA JOLLA TORREY PINES, LA JOLLA, CA

For more information please contact Sarah Nackson, Coordinator, Training Programs & CSSG at 908-233-4508 or snackson@jeiven.com

DCAT Week

Mon, 16 Mar 2009 04:00:00 GMT

Waldorf-Astoria Hotel
New York City, NY

DCAT Week is the premier business development event and is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical, nutritional and related industries.

To pre-arrange a meeting with one of our representatives, please email info@aptuit.com

Drug Delivery to the Lung 020

Wed, 09 Dec 2009 14:58:00 GMT

Edinburgh International Conference Center (EICC)
Edinburgh, Scotland, UK

The premiere European conference for the presentation of lectures and posters relating to the development of inhalers for the treatment of both respiratory diseases and also for systemic drug delivery.

For the fifth year running the DDL Conference will return to Edinburgh. The meeting format will consist of a series of themed podium sessions on the science, technology and regulation of drug delivery to the lungs, plus a combined display area for scientific posters and supplier exhibits.

Aptuit will be exhibiting at this event, to pre-arrange a meeting with one of our representatives please email info@aptuit.com

DIA 2009

Sun, 21 Jun 2009 16:00:00 GMT

The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, best-value, global, multidisciplinary event.

The Annual Meeting welcomes attendees from all geographic locations, professional categories, and levels of responsibility – making it the perfect venue for blending multidisciplinary learning with global networking opportunities.

Geographic Locations

Africa
Asia
Australia
Europe
North America
South America

Prefessional Categories

Academic
Government
Healthcare
Industry

Levels of Responsibility

Departmental, divisional or group functions
Overall organizational functions
Specialized function or job within a group or division

DIA 2010

Sun, 13 Jun 2010 16:00:00 GMT

The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, best-value, global, multidisciplinary event.

Geographic Locations

Africa
Asia
Australia
Europe
North America
South America

Prefessional Categories

Academic
Government
Healthcare
Industry

Levels of Responsibility

Departmental, divisional or group functions
Overall organizational functions
Specialized function or job within a group or division

Aptuit will be exhibiting at this event. To meet with one of our industy renowned experts email info@aptuit.com

Indiana Life Sciences Forum 2008

Mon, 20 Oct 2008 16:00:00 GMT

The Westin Indianapolis, Indianapolis, IN

The Indiana Life Sciences Forum, presented by Burrill & Company and Biocrossroads, brings together venture capitalists, thought leaders, CEO's, and bankers to discuss and plan the future of Indiana's life sciences industry.

To pre-arrange a meeting with an Aptuit representative please contact info@aptuit.com

Informex 2010

Tue, 16 Feb 2010 17:00:00 GMT

Informex is the essential annual event for sophisticated chemistry, where a comprehensive network of qualified buyers and sellers from the global chemical, pharmaceutical and biotech industry gather to find new customers and suppliers, evaluate current outsourcing projects and discover new applications for chemistry technology. The casual, yet professional, networking atmosphere that Informex offers to the chemical community is unmatched by any other business event.

Visit Aptuit at booth #1001. To pre-arrange a meeting with one of our representatives, please email info@aptuit.com

IPO Annual Meeting 2009

Sun, 13 Sep 2009 16:00:00 GMT

Aptuit Consulting will attend this event

Improving Solubility 2008

Tue, 24 Jun 2008 16:00:00 GMT

Thistle Marble Arch Hotel, LONDON - It is estimated that 40 to 50 percent of new chemical entities (NCEs) are sparingly soluble compounds that require specialised formulations. Approximately 40 percent of lipophilic drug candidates fail to reach market due to poor bioavailability, even though these drugs might exhibit potential pharmacodynamic activities. Evaluating and enhancing solubility and bioavailability is essential for the more effective development of poorly soluble compounds. Where are your formulation studies focused? Are they the most effective they could be? Attend Improving Solubility 2008 to benchmark your processes and maximise your formulation investment. - Dr Ann Newman, Vice President R&D at Aptuit, Inc. Will be speaking on Form Selection To Improve Solubility at this event.

ISPE 2008 Annual Meeting

Sun, 26 Oct 2008 16:00:00 GMT

Pharmaceutical manufacturing industry professionals from around the world will gather this October at ISPE 2008 Annual Meeting in Boca Raton, Florida, USA, to share expertise and gain insight to navigate the horizon of industry change.

Education sessions follow seven tracks of interest: Regulatory, Innovation, Manufacturing Operations, Engineering Design, Investigational Products, Project Management, and Efficient and Effective Compliance. Networking activities, exhibits, and special events allow for one-on-one time with colleagues for further knowledge and best practice sharing.

Aptuit will attend this meeting

ISPE 2009 Washington Conference

Mon, 01 Jun 2009 16:00:00 GMT

JW Marriott, Pennsylvania Avenue, Washington, DC

Attend two-day seminars, planned and delivered by subject matter experts who work in the field every day. Detailed descriptions and agendas will be posted by 1 March 2009.

Topics include:

18th Annual Barrier Isolation Technology Forum Innovation Updates and New Case Studies
Product Quality Lifecycle Implementation
Packaging Challenges: Now and in the Future for Investigational and Commercial Products
Fully Integrated Approaches to Commissioning, Qualification, and Validation Inclusive of Computer Systems Validation
Applied Risk Management – Addressing Cross Industry Challenges
Global Supply Chain Security
Renovation
GAMP® GPG on PCS Ver. 2 and Calibration Guide, Ver. 2

Aptuit's Lois Johnson, Senior Director, Quatlity Assurance will be speaking at this event. The title of her talk will be
Pharmaceutical Outsourcing and Regulatory Oversight – Know Your Agency

ISPE Europe

Mon, 15 Sep 2008 16:00:00 GMT

Manchester, UK - The Lowry Hotel

ISPE conference seminars connect you with experts from around the world, for information on the latest industry innovations, and for the type of collaboration that drives industry direction. ISPE draws from the expertise of its high profile member base to develop a curriculum that addresses current pharmaceutical manufacturing and biotechnology industry demands.

Aptuit will attend this conference and have a table top display. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com.

ISPE Europe

Wed, 30 Sep 2009 04:00:00 GMT

Palais des Congrès, Strasbourg, France

ISPE conference seminars connect you with experts from around the world, for information on the latest industry innovations, and for the type of collaboration that drives industry direction. ISPE draws from the expertise of its high profile member base to develop a curriculum that addresses current pharmaceutical manufacturing and biotechnology industry demands.

Aptuit will attend this conference and have a table top display. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com.

ISPE Europe

Wed, 22 Sep 2010 04:00:00 GMT

Sheraton Hotel, Brussels, Belgium

ISPE conference seminars connect you with experts from around the world, for information on the latest industry innovations, and for the type of collaboration that drives industry direction. ISPE draws from the expertise of its high profile member base to develop a curriculum that addresses current pharmaceutical manufacturing and biotechnology industry demands.

Aptuit will attend this conference and have a table top display. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com.

ISSX Europe Meeting 2008

Sun, 18 May 2008 16:00:00 GMT

Austria Center Vienna, AUSTRIA -

This meeting provides an extremely valuable and truly unique opportunity for Xenobiotic researchers to gather, exchange ideas and expertise. In addition to an outstanding scientific program, which features preclinical aspects, clinical aspects, and new applications of drug development in the 21st century, the ISSX 10th European Regional Meeting provides you with access to state-of-the-art exhibits and poster presentations.

- Aptuit will be exhibiting on stand 51 at this event. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com

ISSX Europe Meeting 2008

Sun, 17 May 2009 16:00:00 GMT

Lisbon, Portugal

This meeting provides an extremely valuable and truly unique opportunity for Xenobiotic researchers to gather, exchange ideas and expertise. In addition to an outstanding scientific program, which features preclinical aspects, clinical aspects, and new applications of drug development in the 21st century, the ISSX 11th European Regional Meeting provides you with access to state-of-the-art exhibits and poster presentations.

Aptuit will be exhibiting at this event. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com

Massachusetts Bio Council Presentation

Wed, 19 Nov 2008 17:00:00 GMT

Jim Vath, PhD, CSO, Zafgen and Robert Burford, PhD, Managing Director, Aptuit Consulting will present, The Virtues of Accelerated Virtual Drug Development, to the Massachusetts Biotechnology Council on November 19, 2008.

Given the current and foreseeable economic environment, companies from early stage and emerging biotechs to large pharmaceutical firms are being forced to do more with less. In an effort to reduce and/or minimize direct expenditures, outsourcing has become part of many a company’s development strategy eliminating the need to incur long term funding commitments for infrastructure. Numerous options now exist for outsourcing but too often lack integration resulting in limited productivity gains. To address this issue there is a paradigm shift underway in drug development by some in the pharmaceutical industry from what was a FIPCO (fully-integrated pharmaceutical company) model to a VIPNET (virtually-integrated pharmaceutical network) model. Creation of novel business arrangements between sponsors and vendors are giving rise to accelerated development in a virtual world where realization of both time and cost savings are clearly apparent. This seminar will describe the benefits and challenges of virtual drug development along with a novel approach accomplished through a Virtual Drug Development Agent and show how it is created, and operated along with its features and benefits.

Midwest Clinical Supply Group Conference

Sun, 27 Apr 2008 16:00:00 GMT

Caesar’s Hotel, Atlantic City, NJ-

The objective of the MCSG conference is to provide a forum for the open exchange of ideas, regulatory changes, technological advances, and information of a non-confidential nature related to clinical supply activities.

Aptuit will attend this conference and have a table top display. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com.

Midwest Clinical Supply Group Annual 2009 Meeting

Sun, 26 Apr 2009 16:00:00 GMT

The Midwest Clinical Supplies Group (MCSG) is proud to announce our 2009 Annual Meeting is being held April 26 - 29th at the Arizona Grand Resort in Phoenix, Arizona.

MCSGpride themselves on consistently bringing you the most affordable educational programming specifically designed for the Clinical Supply professional.

Pacific Region Clinical Supplies PARCS

Fri, 24 Apr 2009 16:00:00 GMT

An informal, regional focus group devoted to dissemination, sharing and discussion of technology, logistics, regulatory issues and best practices involved in implementing the Investigational Clinical Supply Process.

Click herefor the full program and speakersClick herefor the registration formFriday, April 24, 20098:30 AM - 5:00 PMCoffee and Registration starts at8:00 AM

The Westgate Hotel(800) 524-4802San Diego, CA

Contact: David Bernstein(510) 658-3334 Phone(510) 658-3335 Fax

Pharmaceutical Ingredients Japan, 2009

Wed, 01 Jul 2009 16:00:00 GMT

Tokyo Big Sight, Japan

Pharmaceutical Ingredients Japan 2009 is an international trade fair specialised for pharmaceutical/cosmetic ingredients. Approximately 63,000 visitors who deal with ingredients selection, will gather from worldwide for networking and business meetings. If you are looking for efficient business opportunity in Japan and Asian ingredients market, this is the show to visit.

Aptuit will be sponsoring and exhibiting at this event. If you wish to prearrange a meeting with an Aptuit representative please email
info@aptuit.com

Polymorph and Crystalization 2009

Wed, 11 Mar 2009 16:00:00 GMT

Thistle Marble Arch, London, UK

Simplify Your Polymorph Screening and Crystal Growth Strategies to Ensure Effective Scale-Up.

Dr Fiona Thorley, Research Director will be speaking at this event and the team will be exhibiting also. To prearrange a meeting with an Aptuit representative please contact info@aptuit.com

Respiratory Drug Delivery 2008

Sun, 11 May 2008 16:00:00 GMT

Scottsdale, Arizona, Westin Kierland Resort & Spa -

Respiratory Drug Delivery 2008 will focus around in-depth discussions of many developing issues surrounding aerosol drug delivery including new therapeutic opportunities and drug design technologies, progress in drug development alongside novel in vitro and in vivo testing methods, regulatory science, and much more. The seminar will also include a scientific poster session and technology exhibition.

Aptuit will attend this conference and have a table top display. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com.

Aptuit to offer short courses on Pharmaceutical Solids: Essential Knowledge and Advanced Concepts

Tue, 01 Apr 2008 16:00:00 GMT

This course is aimed at professionals in the field of pharmaceutical solids who would like to expand their knowledge base. Presenters will discuss strategic approaches to understanding and predicting the properties and pharmaceutical behavior of solids, as well as the important area of regulatory aspects of pharmaceutical solids. The course will address the following questions:

When are polymorphs important?
What types of studies are required to characterize polymorphs?
What should be done to characterize amorphous solids?
How can stability and rates of transformation be analyzed and predicted?
How is the polymorph or hydrate present related to stability?
What specifications should be set and how can analytical procedures for mixtures of solids be developed and validated?
What is required in a regulatory submission (Q6A) and how should it be approached?

This course will be offered three times throughout 2008.

Arlington, VA– April 8-10, 2008 Click here for full details

Macclesfield, England– April 23-25, 2008 Click here for full details

San Francisco, CA- May 14-15, 2008 Click here for full details

Society of Toxicology Annual Meeting 2009

Sun, 15 Mar 2009 16:00:00 GMT

Baltimore Convention Center
Baltimore, Maryland

The SOT Annual Meeting provides an industry opportunity to come together to learn about the latest scientific acheivements from a myriad of experts in the field of toxicology.

Visit Aptuit at booth #2902. To pre-arrange a meeting with one of our representatives, please email info@aptuit.com

SPS 2008

Mon, 22 Sep 2008 16:00:00 GMT

Monona Terrace Community and Convention Center
Madison, WI

The Safety Pharmacology Society Annual Meeting is the premier educational event for the safety pharmacology industry. The meeting offers a comprehensive program of continuing education courses to promising young scientists working in small biotechnology companies and senior management from large international pharmaceutical holdings.

Aptuit will be exhibiting at booth #306. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com

SPS 2009

Tue, 15 Sep 2009 04:00:00 GMT

Strasbourg, France

The Safety Pharmacology Society Annual Meeting is the premier educational event for the safety pharmacology industry. The meeting offers a comprehensive program of continuing education courses to promising young scientists working in small biotechnology companies and senior management from large international pharmaceutical holdings.

Aptuit will be exhibiting at this event. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com

SPS 2010

Mon, 20 Sep 2010 04:00:00 GMT

The Seaport Hotel and Convention Centre, Boston MA

The Safety Pharmacology Society Annual Meeting is the premier educational event for the safety pharmacology industry. The meeting offers a comprehensive program of continuing education courses to promising young scientists working in small biotechnology companies and senior management from large international pharmaceutical holdings.

Aptuit will be exhibiting at this event. If you would like to pre-arrange a meeting with one of our representatives, please email info@aptuit.com

Aptuit Consulting Inc., announces appointment of Bernard Olsen, Ph.D. as Managing Director

Thu, 29 Jan 2009 17:00:00 GMT

Aptuit, Inc. Ramps up Investment in India with Acquisition of IT

Wed, 15 Feb 2006 05:00:00 GMT

Company to Make Significant Investments Over the Next Five Years in India

Aptuit Completes InfoPro Solutions Acquisition, Launches Informatics Business Line

Wed, 15 Mar 2006 04:00:00 GMT

InfoPro Solutions Deal Brings Proven Clinical Informatics Solutions to Aptuit Informatics, New Business Line to Offer Integrated Platform to Manage Global Drug Development Projects

Aptuit Appoints Stuart Needleman Senior Director, Active Pharmaceutical Ingredient Development

Mon, 20 Mar 2006 04:00:00 GMT

Needleman to Lead Efforts to Increase Active Pharmaceutical Ingredient Capabilities Through Strategic Acquisitions and Additional Internal Investments

Aptuit Secures Additional Private Equity Funding, Bringing Potential Capital Available to More Than $750 Million

Mon, 10 Apr 2006 16:00:00 GMT

Temasek Holdings Makes Minority Investment, Adds John Nine to Aptuit’s Board of Directors

Global Pharmaceutical Development, Inc., Becomes Aptuit

Tue, 05 Jul 2005 04:00:00 GMT

Name Change Sets Stage for New Phase of Company Growth and Investment

Aptuit to Acquire Quintiles’ Pharmaceutical Sciences, Preclinical Services and Clinical Trial Supplies

Tue, 19 Jul 2005 04:00:00 GMT

Provides Foundation for Comprehensive Drug Development; Marketing Agreement Offers Continuum of Services

Aptuit to Acquire Almedica International

Mon, 29 Aug 2005 04:00:00 GMT

Acquisition Significantly Expands Clinical Trial Material Supply Capabilities and Customer Support, Jumps Aptuit to Largest Global Provider by Capacity

Aptuit, Inc. Completes Acquisition of Almedica International

Wed, 28 Sep 2005 04:00:00 GMT

Deal Close Marks Another Milestone in Company’s Vision to Engineer a Better Drug Development Process

Aptuit Vaults to Sector Leadership, Unveils New Global Management Team

Mon, 03 Oct 2005 04:00:00 GMT

Announcement of Senior Management Coincides with 2nd major acquisition

Aptuit Wins Prestigious Scottish Training Award For Innovative Management Training Program

Fri, 04 Nov 2005 04:00:00 GMT

Award Highlights Aptuit’s Dedication to Provide Customers with Accessible and Experienced Management To Streamline Drug Development Process

Aptuit to Acquire InfoPro Solutions, Developer of the Clinical Supplies Industry Standard Clinicopia® Suite

Mon, 14 Nov 2005 05:00:00 GMT

Acquisition Adds Robust Informatics Services to Aptuit Portfolio, Designed to Enable Seamless, Multi-Site, Real Time Customer Access to Drug Development Data and Information

Paul Lubetkin Joins Aptuit, Inc. as General Counsel

Mon, 28 Nov 2005 05:00:00 GMT

Lubetkin Adds Significant Experience in Handling Complex Legal and Regulatory Matters in the Healthcare Industry to Aptuit’s Management Team

Aptuit Names Vito Saccente Senior Director, Sales for North America

Tue, 27 Jun 2006 04:00:00 GMT

Strategic Hire Strengthens Company’s Sales Force and U.S. Presence

Aptuit to Acquire Active Pharmaceutical Ingredients (API) Business from EaglePicher

Tue, 26 Sep 2006 13:35:01 GMT

Acquisition begins a phase of significant expansion of Aptuit’s API Development offerings, including post-market commercial drug manufacture

Dr. Marcello DiMare appointed Senior Director, Chemistry Development at Aptuit

Mon, 02 Oct 2006 04:00:00 GMT

DiMare brings clinical and management expertise to rapidly expanding API business

Aptuit Announces Appointment of Timothy C. Tyson as Executive Chairman and CEO

Tue, 26 Aug 2008 16:00:00 GMT

Aptuit Appoints Thierry Amat as Chief Financial Officer

Mon, 08 Sep 2008 15:20:28 GMT

Adds Extensive Experience in Financial Management in the Pharmaceutical and Chemical Industries to Aptuit’s Management Team

Aptuit Launches Program to Accelerate Early Stage Drug Development

Wed, 01 Oct 2008 12:59:24 GMT

Aptuit INDiGO™ accelerates drug development from pre-clinical candidate selection to regulatory filing on a fixed timeline and price

Aptuit Consulting Announce Key Additions to Global Consulting Team

Wed, 24 Sep 2008 16:00:00 GMT

Aptuit Consulting Announces Dr. William Kerns to Head Aptuit Consulting

Fri, 08 Aug 2008 16:00:00 GMT

Aptuit Consulting Announces Dr. William Kerns to Head Aptuit Consulting and Mark Nedelman as Director of Business Development

Peter J. Adamski joins Aptuit as Chief Financial Officer

Wed, 10 Jan 2007 05:00:00 GMT

Aptuit adds Extensive Experience in Accounting, Financial Planning, Analysis, Forecasting and Mergers and Acquisitions to Aptuit’s Management Team

Aptuit to Acquire SSCI

Wed, 25 Oct 2006 16:00:00 GMT

Acquisition Expands Capabilities to Include Solid-State Pharmaceutical Product Development

Aptuit Completes Acquisitions of EaglePicher Pharmaceutical Services and SSCI

Thu, 01 Feb 2007 05:00:00 GMT

Extended Service Offering Creates Solid Drug Development Foundation, Allowing Customers To Get it Right the First Time

Aptuit Deploys Clinicopia® Labeling Solution at Global Clinical Packaging and Logistics Facilities

Mon, 16 Oct 2006 16:00:00 GMT

Launch of Best-of-Breed Clinical Labeling Technology Marks Successful Milestone Toward Global Deployment of Entire Clinicopia Suite

Announcement: Aptuit Consulting Announces the Addition of Two Leading Pharmaceutical Industry Experts to the Consulting Team

Fri, 06 Oct 2006 20:31:37 GMT

Dr. Kei-Lai Fong and Dr. Mary Sherman bring extensive pharmaceutical experience to Aptuit Consulting

Aptuit To Invest An Additional $100 Million In Operations, Elevate Key Executives

Tue, 20 Feb 2007 05:00:00 GMT

Strong Organic Revenue Growth, Strategic Acquisitions and New Leadership Structure Usher in New Phase, Focused on Global Integration, Industry Leading R&D Performance

Aptuit Consulting Continues to Grow with the Addition of New Hires

Thu, 18 Jan 2007 17:00:00 GMT

Aptuit Acquisition of Evotec AG CPD business completes unique global API development supply chain

Mon, 03 Dec 2007 05:00:00 GMT

Acquisition brings additional API development and manufacturing capability and sterile fill, finish; Aptuit remains on track to create a fully integrated global drug development company operating with their customers in a truly efficient paperless environment

Aptuit Announces Launch of Aptuit Consulting Inc.

Tue, 23 May 2006 04:00:00 GMT

Establishment of Distinct Business Unit Coincides with Acquisition of Pharma Consulting Inc.; Adds Leading Pharma Industry Experts to Guide Innovators through the Drug Development Process

Aptuit Advances Key Leader, Plans for Expansion of Global Clinical Packaging and Logistics Capacity, Launches Next Clinicopia® Solution

Thu, 10 May 2007 04:00:00 GMT

Advanced Version of Clinical Trial Management Technology Marks Second Major Milestone Toward Global Roll-Out of Entire Clinicopia Suite

Danube Pharmaceuticals Taps Aptuit for Integrated Phase II Drug Development Project

Mon, 04 Jun 2007 04:00:00 GMT

Danube Will Draw on Full Range of Aptuit Resources Across Its Global Network, From API Development Through to Qualified Person Release and Manufacture for Clinical Trial Materials

Aptuit Introduces Aptuit IVRS powered by Clarix, a Fully Web-Integrated Interactive Voice Response System Providing Customers with Easy Access to Real-Time Data

Mon, 09 Jul 2007 04:00:00 GMT

Aptuit makes minority investment in Clarix; Advanced IVR System provides users with unparalleled functionality both over the phone and on the Web

Aptuit to acquire CPD business of Evotec AG, and enter into long-term collaborative supply agreement for Evotec’s growing portfolio of proprietary pharmaceuticals

Mon, 10 Sep 2007 04:00:00 GMT

European active pharmaceutical ingredient (API) capability completes a global API network and positions Aptuit to transfer to commercial scale in India; Parenteral fill/finish capabilities in UK adds to existing capacity in US to meet growing client demand for small-scale sterile formulation and manufacture

Organizational Announcement - North American Sales Team

Fri, 15 Jun 2007 04:00:00 GMT

Aptuit Inc. are pleased to announce organizational appointments to the Sales and Client services team in North America.

Operational Announcement - Scientific Operations

Fri, 15 Jun 2007 04:00:00 GMT

Aptuit are pleased to announce organizational improvements and new senior leadership appointments to our Pharmaceutics and PAC organizations in N. America and Europe

Aptuit to invest more than $100 million in Laurus Labs (India); Dr. Satyanarayana Chava named Aptuit Laurus CEO, joins Aptuit Board

Sun, 17 Jun 2007 04:00:00 GMT

Joint Venture, Aptuit Laurus, to offer Contract Drug Development from Two World Class R&D and Manufacturing Facilities in Hyderabad and Vishakhapatnam, and Software Development and Informatics Services

Aptuit makes the news

Wed, 20 Jun 2007 04:00:00 GMT

Aptuit Consulting Inc., announces appointment – Jeffrey Wilson, Ph.D.

Tue, 21 Aug 2007 04:00:00 GMT

Aptuit Consulting is pleased to announce the appointment of Jeffrey Wilson Ph.D., to the position of Managing Director, CMC practice. He will be located in the Lexington MA office of the company.

Robert Burford, PhD, and Managing Director with Aptuit Consulting to speak at Bio International Convention

Mon, 19 May 2008 04:00:00 GMT

Aptuit Consulting Expands Global Consulting Services

Mon, 11 Feb 2008 05:00:00 GMT

Aptuit Appoints Michael J. Butler Ph.D. President, Scientific Operations

Wed, 19 Apr 2006 04:00:00 GMT

The Combination of Scientific Excellence, Business Process Improvement and Customer Objectives will Further Establish Aptuit as a Leader in the Drug Development Services Industry

Aptuit Consulting Inc. and Taiwan Liposome Company (TLC) Collaborate to Complete all IND Enabling Work and IND Submission for Novel Anti-Cancer Treatment in 12 Months

Wed, 25 Jun 2008 14:36:52 GMT

Aptuit Consulting Inc. and Taiwan Liposome Company (TLC) Collaborate to Complete all IND Enabling Work and IND Submission for Novel Anti-Cancer Treatment in 12 Months

Sotox Emailer

Fri, 27 Feb 2009 17:00:00 GMT

API - Timely API Supply

Tue, 27 Jan 2009 17:00:00 GMT

Consulting

Wed, 30 Apr 2008 04:00:00 GMT

Aptuit Laurus

Wed, 16 Jan 2008 05:00:00 GMT

CFS1200

Mon, 05 Nov 2007 05:00:00 GMT

Clinicopia

Mon, 10 Mar 2008 04:00:00 GMT

Clinical Supplies

Mon, 10 Dec 2007 05:00:00 GMT

Toxicology

Tue, 08 Apr 2008 04:00:00 GMT

Aptuit INDiGO TM

Tue, 24 Mar 2009 16:00:00 GMT

Aptuit Laurus - High Potent Capabilities

Tue, 30 Sep 2008 16:00:00 GMT

Clinicopia 4.2

Tue, 09 Sep 2008 16:00:00 GMT

Clinicopia Labeling

Tue, 03 Mar 2009 17:00:00 GMT

We've expanded our reach...

Wed, 23 Jul 2008 16:00:00 GMT

Aptuit Consutling eSubmissions Capabilities

Fri, 05 Sep 2008 16:00:00 GMT

Fast LC Method

Tue, 06 Jan 2009 17:00:00 GMT

Applied Immunology at Aptuit

Mon, 22 Dec 2008 17:00:00 GMT

Metabolites in Safety Testing

Fri, 20 Jun 2008 16:00:00 GMT

New Packaging Facility

Mon, 20 Oct 2008 16:00:00 GMT

Pharmaceutics - Overencapsulation Unit

Tue, 10 Feb 2009 17:00:00 GMT

Solving Drug Development COncerns

Wed, 24 Sep 2008 16:00:00 GMT

DMPK and Custom Radiosynthesis Services

Tue, 28 Apr 2009 16:00:00 GMT

Solid-State Chemistry

Wed, 28 May 2008 16:00:00 GMT

PCT

Thu, 27 Sep 2007 04:00:00 GMT

Livingston

Thu, 13 Sep 2007 04:00:00 GMT

Depot

Tue, 07 Aug 2007 04:00:00 GMT

Flow Power

Mon, 09 Jul 2007 04:00:00 GMT

DMPK

Thu, 14 Jun 2007 04:00:00 GMT

Software

Tue, 29 May 2007 04:00:00 GMT

API

Sun, 13 May 2007 04:00:00 GMT

Consulting

Tue, 01 May 2007 04:00:00 GMT

SAB

Tue, 10 Apr 2007 04:00:00 GMT

Partnership

Mon, 02 Apr 2007 04:00:00 GMT

The Road to API - DIA Annual Meeting

Wed, 18 Jun 2008 16:00:00 GMT

Toxicology

Wed, 12 Mar 2008 16:00:00 GMT

Streamlining Clinical Supplies for Global Trials

Fri, 12 Jun 2009 04:00:00 GMT

Aptuit Laurus Facilities Tour

Wed, 13 Aug 2008 16:00:00 GMT

Aptuit Laurus Facilities Tour

Visualizing Polymorphism - The Journey from Molecules to Crystals

Sun, 20 Jul 2008 04:00:00 GMT

Polymorphism, the ability of a molecular species to crystallize in different packings based upon different crystallization conditions, observed often among organic compounds. Different crystal packings of compounds are responsible for the smooth taste of chocolate as well as the ability of drug compounds to dissolve in the body. This animation illustrates the preparation of two different polymorphs of acetaminophen under two different crystallization conditions based on data collected at Aptuit. Form A, the more stable form, is the commercially available form and is not directly compressible into tablets. Form B, the less stable form, is directly compressible into tablets without excipients, but is physically not stable enough to commercialize.

Molecular Design as a Strategy for Solving the Critical Path Problem

9/8/2008 4:00:00 AM

Dr. Stephen Byrn speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process.

Informatics and clinical supply chain management: A stronger link for the drug development

9/8/2008 4:00:00 AM

Doug Meyer, Senior Director for Aptuit Informatics, discussing the role and importance of informatics in today's clinical trial environment

Redefining the CRO

5/7/2008 4:00:00 AM

Bob Burford Ph.D. discusses the relationship between drug developers and CROs

Corporate Brochure

6/27/2007 4:00:00 AM

Aptuit's Corporate Brochure